0.7608
price up icon3.99%   0.0292
after-market After Hours: .76 -0.0008 -0.11%
loading

Filana Therapeutics Inc Stock (FLNA) Forecast

The Filana Therapeutics Inc (FLNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5451, representing a -28.35% decrease from the current price of $0.7608. The highest analyst price target is $0.6846, and the lowest is $0.4056.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FLNA Price Target
Average 0.4041 (-46.88% Downside)
loading

Is Filana Therapeutics Inc (FLNA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 43.86 Neutral
STOCH(9,6) 13.52 Buy
STOCHRSI(14) 18.04 Buy
MACD(12,26) -0.0247 Sell
ADX(14) 27.95 Buy
William %R -82.60 Buy
CCI(14) -78.92 Neutral
Buy: 4 Sell: 1 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
0.8127
Sell
0.794
Sell
MA20
0.8321
Sell
0.8154
Sell
MA50
0.8582
Sell
0.8788
Sell
MA100
1.0239
Sell
1.0454
Sell
MA200
0.9278
Sell
0.00
Buy
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, FLNA could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 10 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on FLNA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 43.86 indicates that FLNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 13.52 indicates that FLNA is oversold. This indicates that FLNA price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.04 indicates that FLNA is oversold. This suggests that FLNA price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 27.95 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -78.92 indicates that FLNA is still oversold but not to an extreme extent.

Long-term FLNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Filana Therapeutics Inc financial reports and earnings history, Filana Therapeutics Inc (FLNA) stock could reach $2.8674 by 2030, $13.49 by 2040 and $21.41 by 2050. See the projected annual prices until 2050 of the Filana Therapeutics Inc stock below:

  • Filana Therapeutics Inc (FLNA) is expected to reach an average price of $7.7354 in 2035, with a high prediction of $8.501 and a low estimate of $7.7437. This indicates an $916.74% rise from the last recorded price of $0.7608.
  • Filana Therapeutics Inc (FLNA) stock is projected to chart a bullish course in 2040, with an average price target of $11.95, representing an $1,470% surge from its current level. The forecast ranges from a conservative $11.97 to a sky-high $13.49.
  • Our analysts predict Filana Therapeutics Inc (FLNA) to jump 1,961% by 2045, soaring from $15.70 to an average price of $15.68, potentially reaching $17.69. While $15.70 is the low estimate, the potential upside is significant.
  • Filana Therapeutics Inc (FLNA) stock is expected to climb by 2050, reaching an average of $18.80, a $2,371% jump from its current level. However, a wide range of estimates exists, with high and low targets of $21.41 and $18.86, respectively, highlighting the market's uncertainty.

Filana Therapeutics Inc Stock (FLNA) Year by Year Forecast

Filana Therapeutics Inc Stock (FLNA) Price Forecast for 2026

The predicted value for Filana Therapeutics Inc (FLNA) in 2026 is set at an average of $1.2469. Estimates vary from a peak of $2.2665 to a trough of $0.2273, indicating an +63.89% surge from the present price of $0.7608.
Month Average Low High Change from today's price
November, 2026 $0.6006 $0.4056 $0.6846 -21.05%
December, 2026 $0.2567 $0.2273 $0.6921 -66.26%

Filana Therapeutics Inc Stock (FLNA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Filana Therapeutics Inc (FLNA) is $0.4041, with a high forecast of $0.7298 and a low forecast of $0.0784. This indicates an -46.88% decrease from the last price of $0.7608.
Month Average Low High Change from today's price
January, 2027 $0.3627 $0.1382 $0.6427 -52.33%
February, 2027 $0.3187 $0.2557 $0.5642 -58.11%
March, 2027 $0.2463 $0.0927 $0.5397 -67.63%
April, 2027 $0.2513 $0.1521 $0.3293 -66.97%
May, 2027 $0.1779 $0.0784 $0.7298 -76.61%
June, 2027 $0.2475 $0.1713 $0.5128 -67.47%
July, 2027 $0.6978 $0.5668 $0.6678 -8.29%
August, 2027 $0.7227 $0.6157 $0.5647 -5.01%
September, 2027 $0.6906 $0.6897 $0.6944 -9.22%
October, 2027 $0.6086 $0.5976 $0.5386 -20.01%
November, 2027 $0.5535 $0.5065 $0.5156 -27.25%
December, 2027 $0.5281 $0.5364 $0.5117 -30.58%

Filana Therapeutics Inc Stock (FLNA) Price Forecast for 2028

In 2028, Filana Therapeutics Inc (FLNA) is projected to reach an average price of $1.5916, with a high projection of $3.0555 and a low estimate of $0.1277. This indicates an +109.20% rise from the last price of $0.7608.
Month Average Low High Change from today's price
January, 2028 $0.4538 $0.4302 $0.4106 -40.36%
February, 2028 $0.1234 $0.1277 $0.4134 -83.78%
March, 2028 $1.9207 $0.2363 $1.6807 +152.46%
April, 2028 $1.8126 $1.8126 $1.8616 +138.25%
May, 2028 $1.83 $1.7236 $1.629 +140.53%
June, 2028 $1.5519 $1.5764 $1.7163 +103.98%
July, 2028 $1.3193 $1.3693 $1.4529 +73.41%
August, 2028 $1.2812 $1.3348 $1.2969 +68.40%
September, 2028 $1.1041 $1.1231 $1.1917 +45.13%
October, 2028 $0.9624 $0.9817 $1.0386 +26.50%
November, 2028 $0.7208 $0.6549 $0.6993 -5.25%
December, 2028 $3.0855 $3.0836 $3.0555 +305.56%

Filana Therapeutics Inc Stock (FLNA) Price Forecast for 2029

The 2029 price forecast for Filana Therapeutics Inc Stock (FLNA) is $2.7157 on average, with a high prediction of $4.2494 and a low estimate of $1.182. This represents an +256.95% increase from the previous price of $0.7608.
Month Average Low High Change from today's price
January, 2029 $2.8954 $2.8314 $2.9095 +280.57%
February, 2029 $2.6913 $2.8193 $2.7381 +253.74%
March, 2029 $2.4371 $2.4871 $2.3671 +220.34%
April, 2029 $2.167 $2.163 $2.3011 +184.83%
May, 2029 $1.9696 $1.9779 $2.0822 +158.88%
June, 2029 $1.7187 $1.7368 $1.8091 +125.90%
July, 2029 $1.1777 $1.182 $1.6327 +54.80%
August, 2029 $4.3945 $1.2207 $4.1545 +477.61%
September, 2029 $4.1143 $4.1143 $4.2494 +440.79%
October, 2029 $3.9166 $3.8842 $3.8768 +414.81%
November, 2029 $3.4665 $3.4965 $3.7599 +355.64%
December, 2029 $3.0188 $3.0688 $3.2814 +296.80%

Filana Therapeutics Inc Stock (FLNA) Price Forecast for 2030

Filana Therapeutics Inc Stock (FLNA) is expected to reach an average price of $3.574 in 2030, with a high forecast of $5.4433 and a low forecast of $1.7048. This signifies an +369.77% surge from the last price of $0.7608.
Month Average Low High Change from today's price
January, 2030 $2.8087 $2.9623 $2.8674 +269.17%
February, 2030 $2.4595 $2.4785 $2.6761 +223.28%
March, 2030 $2.2324 $2.2883 $2.351 +193.43%
April, 2030 $1.6891 $1.7048 $1.7966 +122.02%
May, 2030 $5.4733 $5.5433 $5.4433 +619.41%
June, 2030 $5.0371 $5.0471 $5.2542 +562.08%
July, 2030 $4.6919 $4.8269 $4.8881 +516.70%
August, 2030 $4.2657 $4.3157 $4.2828 +460.69%
September, 2030 $3.7805 $3.7905 $4.0867 +396.91%
October, 2030 $3.411 $3.4193 $3.6527 +348.35%
November, 2030 $2.9881 $3.0062 $3.2075 +292.75%
December, 2030 $2.232 $2.2363 $2.8591 +193.38%
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Cap:     |  Volume (24h):